Comparative Analysis of Sitagliptan vs Empagliflozin as an add on Therapy to Metformin in Pakistani Type 2 Diabetic Patients
Abstract
Introduction: Diabetes is a condition that impairs carbohydrate, fat, and protein metabolism in the body. At the point when we eat food, the food is separated into glucose and supplements and is invested in the blood. Objective: The main objective of the study is to analyse the sitagliptan vs empagliflozin as an add-on therapy to metformin in Pakistani type 2 diabetic patients. Material and methods: This comparative study was conducted with the collaboration of different hospitals of Pakistan in different regions during November 2020 to September 2021. Fasting blood sample was collected for the analysis of serum blood glucose levels and body weight, waist circumference, systolic blood pressure (SBP), and diastolic blood pressure (DBP) were also measured on daily basis. Results: The data was collected from 200 patients. The basic demographic characteristics of all the patients were shown in table 01. There were 86 (43%) male and 114 (57%) female patients. The mean value of HbA1C was 10.07 and 112 patients suffering from hypertension and 46 from heart diseases. Conclusion: It is concluded that empagliflozin is an effective agent in treating patients with type 2 diabetes, with good efficacy and safety profiles.
Read the paper
Related studies
- The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
- Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
- Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model
- Modulating Sirtuin Biology and Nicotinamide Adenine Diphosphate Metabolism in Cardiovascular Disease—From Bench to Bedside
- Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
- Early Treatment with Empagliflozin and GABA Improves β-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.